These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37963646)

  • 1. The PKM2 inhibitor shikonin enhances piceatannol-induced apoptosis of glyoxalase I-dependent cancer cells.
    Inoue M; Nakagawa Y; Azuma M; Akahane H; Chimori R; Mano Y; Takasawa R
    Genes Cells; 2024 Jan; 29(1):52-62. PubMed ID: 37963646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piceatannol, a natural trans-stilbene compound, inhibits human glyoxalase I.
    Takasawa R; Akahane H; Tanaka H; Shimada N; Yamamoto T; Uchida-Maruki H; Sai M; Yoshimori A; Tanuma SI
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1169-1174. PubMed ID: 28169168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells.
    Shimada N; Takasawa R; Tanuma SI
    Arch Biochem Biophys; 2018 Jan; 638():1-7. PubMed ID: 29225125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLSC702, a Novel Inhibitor of Human Glyoxalase I, Induces Apoptosis in Tumor Cells.
    Takasawa R; Shimada N; Uchiro H; Takahashi S; Yoshimori A; Tanuma S
    Biol Pharm Bull; 2016; 39(5):869-73. PubMed ID: 27150153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphenylbismuth dichloride inhibits human glyoxalase I and induces cytotoxicity in cultured cancer cell lines.
    Takasawa R; Jona A; Inoue M; Azuma M; Akahane H; Ueno Y; Nakagawa Y; Chimori R; Mano Y; Murata Y; Yasuike S; Kaji T
    J Toxicol Sci; 2022; 47(12):539-546. PubMed ID: 36450498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
    Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
    Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of hydrophobic side chains improve the apoptosis inducibility of the human glyoxalase I inhibitor, TLSC702.
    Azuma M; Inoue M; Nishida A; Akahane H; Kitajima M; Natani S; Chimori R; Yoshimori A; Mano Y; Uchiro H; Tanuma SI; Takasawa R
    Bioorg Med Chem Lett; 2021 May; 40():127918. PubMed ID: 33711442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis.
    Rihan M; Sharma SS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):145-159. PubMed ID: 37382601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
    Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
    In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2 Is Overexpressed in Glioma Tissues, and Its Inhibition Highly Increases Late Apoptosis in U87MG Cells With Low-density Specificity.
    Park JH; Lee JS; Oh Y; Lee JS; Park HE; Lee H; Park YS; Kyung SY; Kim HS; Yoon S
    In Vivo; 2022; 36(2):694-703. PubMed ID: 35241524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
    Chen J; Xie J; Jiang Z; Wang B; Wang Y; Hu X
    Oncogene; 2011 Oct; 30(42):4297-306. PubMed ID: 21516121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of piceatannol-rich passion fruit seed extract on human glyoxalase I-mediated cancer cell growth.
    Yamamoto T; Sato A; Takai Y; Yoshimori A; Umehara M; Ogino Y; Inada M; Shimada N; Nishida A; Ichida R; Takasawa R; Maruki-Uchida H; Mori S; Sai M; Morita M; Tanuma SI
    Biochem Biophys Rep; 2019 Dec; 20():100684. PubMed ID: 31517069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Wang X; Zhang F; Wu XR
    Sci Rep; 2017 Apr; 7():45983. PubMed ID: 28378811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Featured Article: Pyruvate preserves antiglycation defenses in porcine brain after cardiac arrest.
    Scott GF; Nguyen AQ; Cherry BH; Hollrah RA; Salinas I; Williams AG; Ryou MG; Mallet RT
    Exp Biol Med (Maywood); 2017 May; 242(10):1095-1103. PubMed ID: 28361585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tat-glyoxalase protein inhibits against ischemic neuronal cell damage and ameliorates ischemic injury.
    Shin MJ; Kim DW; Lee YP; Ahn EH; Jo HS; Kim DS; Kwon OS; Kang TC; Cho YJ; Park J; Eum WS; Choi SY
    Free Radic Biol Med; 2014 Feb; 67():195-210. PubMed ID: 24252591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2.
    Liu T; Li S; Wu L; Yu Q; Li J; Feng J; Zhang J; Chen J; Zhou Y; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C
    J Hepatocell Carcinoma; 2020; 7():19-31. PubMed ID: 32110554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism.
    Lin H; Han H; Yang M; Wen Z; Chen Q; Ma Y; Wang X; Wang C; Yin T; Wang X; Lu G; Chen H; Qi J; Yang Y
    Eur J Med Chem; 2023 Mar; 249():115166. PubMed ID: 36731272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
    Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
    Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and dynamic studies of a potential therapeutic target inhibiting glyoxalase system: Metabolic action of the 3, 3 '- [3- (5-chloro-2-hydroxyphenyl) -3-oxopropane-1, 1-diyl] - Bis-4-hydroxycoumarin leads overexpression of the intracellular level of methylglyoxal and induction of a pro-apoptotic phenomenon in a hepatocellular carcinoma model.
    Taïbi N; Al-Balas QA; Bekari N; Talhi O; Al Jabal GA; Benali Y; Ameraoui R; Hadjadj M; Taïbi A; Boutaiba ZM; Abou-Mustapha M; Khammar F; Dergal F; Hassaine R; Boukenna L; Bachari K; Soares Silva AM
    Chem Biol Interact; 2021 Aug; 345():109511. PubMed ID: 33989593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
    Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
    Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.